CDNA
Overvalued by 106.3% based on the discounted cash flow analysis.
Market cap | $1.07 Billion |
---|---|
Enterprise Value | $982.55 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $1 |
Beta | 2.18 |
Outstanding Shares | 55,262,459 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 18.07 |
---|---|
PEG | -47.73 |
Price to Sales | 3.21 |
Price to Book Ratio | 3.21 |
Enterprise Value to Revenue | 2.84 |
Enterprise Value to EBIT | 20.95 |
Enterprise Value to Net Income | 16 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data